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ORIGINAL ARTICLE

Frequency and Characteristic Features of Portal Hypertensive
Gastropathy in Patients with Viral Cirrhosis

Shahid Ahmed, Khalid Mumtaz, Umair Syed Ahmed, Hasnain Ali Shah, Shahab Abid, Saeed Hamid and Wasim Jafri

ABSTRACT
Objective: To determine the frequency and specific characteristic features of portal hypertensive gastropathy (PHG) in
cirrhosis due to viral etiology.
Study Design: Cross-sectional descriptive study.
Place and Duration of Study: The Aga Khan University Hospital, Karachi, from June 2006 till June 2008.
Methodology: Patients with hepatitis B and C cirrhosis were included who underwent screening esophago-gastroduodenoscopy (EGD) for varices. Baveno III consensus statement was used for diagnosing PHG on endoscopy and
divided them into two subgroups i.e. mild and severe. Data related to platelet/spleen ratio, MELD score and Child Turcotte
Pugh (CTP) score indicating severity of cirrhosis were recorded in all patients. Findings were compared by using
independent sample t-test.
Results: Out of 360 patients who underwent screening EGD, 226 (62.8%) were males. Two hundred and eighty one (78%)
had hepatitis C while 79 (22%) suffered from hepatitis B related cirrhosis. Three hundred patients (83.3%) had PHG while
71 (24%) had severe PHG. Higher proportion of esophageal varices (89.7%) was present among those who had PHG
(p < 0.001). On univariate analysis lower platelet counts (117±55 vs. 167±90; p < 0.001), increased spleen size (14.1±2.9 cm
vs. 12±2.4cm; p < 0.001) were found in PHG patients as compared to those without it. Similarly, lower platelet/spleen ratio
was noted in patients with severe PHG (916±400 vs. 1477±899; p < 0.001). Furthermore, on multivariate analysis CTP
score > 8 MELD score > 12 and platelets/spleen ratio < 900 were significantly associated factors with severe PHG.
Conclusion: Frequency of PHG was 83% while severe PHG was seen in 24% cases of viral hepatic cirrhosis. MELD score
> 12, CTP score ≥ 8 and platelets/spleen ratio < 900 were significant factors of severe PHG.
Key words:

Viral. Cirrhosis. Portal. Gastropathy. MELD score. Varices.

INTRODUCTION
Portal hypertension is one of the major complications of
chronic liver disease.1 It develops because of an
increase in splanchnic blood flow secondary to
vasodilatation within the splanchnic vascular bed; and
also because of increased resistance to the passage of
blood through the liver.2
Amongst the complications of chronic liver disease,
portal hypertensive gastropathy (PHG) has emerged as
a new entity in the last two decades. It has been
described as endoscopic appearance of gastric
mucosa, with a characteristic mosaic-like pattern with or
without red spots, and is seen in patients with both
cirrhotic and non-cirrhotic portal hypertension. These
mucosal changes mainly seen in fundus and body of
stomach, but can also be noted in the gastric antrum.
The prevalence of PHG in cirrhotic patients has been
reported to be variable, ranging between 11% and 98%,
while the incidence varies from 25% to 50%.3,4 This
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difference has been often attributed to the absence of a
common classification system, with a subsequent intra
and inter-observer variation.5 The most widely used
classification is Baveno III consensus statement,6
according to it PHG is divided into two subgroups mild
and severe. Mild PHG is defined as mosaic like pattern
without redness of the areola, while severe PHG
consists of mosaic-like pattern superimposed by red
signs. Furthermore, the pattern of gastric antral vascular
ectasia (GAVE), characterized by aggregates of red
spots arranged in a linear pattern or as diffuse lesion, is
generally considered a particular pattern of severe PHG.
The severity of PHG however is dynamic, with some
patients improving and others deteriorating without any
obvious changes noted in liver function.3 Portal
hypertension seems to be key underlying factor in
development of PHG with improvement of PHG following
shunt procedures reinforcing such an association.7
However, studies have also reported that the natural
history of PHG is also influenced by the severity of liver
disease,8 along with presence and size of gastroesophageal varices, and previous variceal eradication
by endoscopic variceal sclerotherapy or banding.3
There are reports to suggest that the esophageal
varices (EV) are seen more frequently in patients with
advanced cirrhosis based on different factors such
as platelet count/spleen diameter ratio, right liver lobe
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diameter/albumin ratio, presence of ascites or thrombocytopenia.9-11 However, there is insufficient regional and
no local data on the frequency, characteristic of PHG
and its severity in patients with viral cirrhosis.12,13
Therefore, the aim of this study was to determine the
frequency and characteristic features of PHG in patients
undergoing screening esophago-gastro-duodenoscopy
(EGD) for varices due to cirrhosis of viral etiology.

METHODOLOGY
Patients with viral cirrhosis undergoing screening EGD
at Aga Khan University Hospital (AKUH) were
retrospectively reviewed from June 2006 to June 2008.
The diagnosis of cirrhosis was established in all patients
with the help of biochemical and ultrasound study of
abdomen showing features of cirrhosis with shrunken
liver, irregular liver margins, regenerative nodules,
splenomegaly and/or dilated portal vein. Out of 360
patients only 79 underwent liver biopsies and were
classified with Knodall classification to have stage IV
fibrosis.
Patients with prior history of gastrointestinal bleeding
secondary to varices, beta blockers use, history of
porto-systemic shunt placements, co-existing illnesses
or infections influencing the liver and spleen such as
lymphoma, leukemia, typhoid and malaria, history of
anti-viral treatment currently or in past; or who have been
on NSAIDs/steroids in last 4 weeks were excluded.
The data of patients undergoing screening EGD were
obtained from Information System Department (ISD) of
Endoscopy Unit, AKUH, and a questionnaire was
designed. The data included age, gender; etiology of
cirrhosis, laboratory parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), total
bilirubin, serum albumin, prothrombin time and platelet
count]. Presence of hepatitis B surface antigen (HBsAg)
and hepatitis C virus (HCV) antibodies by micro enzyme
immunoassay (MEIA) were checked as markers of viral
hepatitis. All patients underwent an ultrasonography
examination of the upper abdomen, during which the
diameter of main portal vein and the size of the spleen
through the hilum was obtained in the right lateral
decubitus position in the coronal plane. Ultrasonographic evidence of splenic varices and ascites was also
noted and the platelet count/spleen diameter ratio
calculated by using laboratory and ultrasonographic
values. The characteristic features studied were Child
Turcotte Pugh (CTP), Model for End Stage Liver
Disease (MELD) score, platelet count/spleen diameter
ratio, bilirubin, albumin, AST, ALT and platelets were
studied based on the laboratory and ultrasonological
work-up performed within last 6 weeks.
All endoscopies were performed by the endoscopists
with at least 5 years of experience, using a GIFQ 160
Gastroscope (Olympus, Tokyo, Japan) in the left lateral

position after obtaining a written informed consent from
the patient. The esophageal varices were divided into
small or large grade (larger than 5 mm in size) according
to Baveno III consensus statement.6 Patients with large
esophageal varices were started on propranolol for the
primary prophylaxis and dose was titrated with heart
rate in follow up clinics. Photo-documentation of
endoscopic findings was performed in four standard
locations of antrum, cardia, retroflexed position and 2-4
cm above gastro-esophageal junction. For identification
of PHG, Baveno III consensus statement was used.6
The cut offs of different factors in previously reported
studies for assessing the severity of cirrhosis such as
platelets counts of < 150,000/cmm, platelet count/
spleen diameter ratio ≤ 900, CTP score of ≥ 8 and
presence of esophageal varies was used.9-11 As the
level of significance for MELD score is not well defined
in literature. It was obtained with the help of receiver
operator curve (ROC). The ROC curve had accuracy of
0.82 and the best cut off for MELD score was 12, with a
sensitivity of 74% and a specificity of 78% (Figure 1).
This study was approved by the Ethics Review
Committee (ERC) of AKUH.

Figure 1: Receiver operating characteristics curve showing the MELD with
the best sensitivity and specificity on the basis of the presence of severe
portal hypertensive gastropathy. AUC, area under the curve.

Statistical analysis performed using Statistical Package
for Social Science SPSS (release 17.0, standard version,
copyright © SPSS; 1989-02). Descriptive analysis was
performed for demographic, clinical and radiographic
features and results were presented as mean ±
standard deviation for quantitative variables and number
(percentages) for qualitative variables.
Patients with cirrhosis were divided into two groups —
those with PHG and without PHG. Chi-square test and
Fisher’s exact test were used for categorical variables,
while independent sample t-test was applied for
numerical variables. Receiver-Operating Characteristics
(ROC) curve was used to determine the cut-off values of
MELD score with the best sensitivity and specificity in
discriminating between patients with mild and severe
portal gastropathy.
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Table I: Demographic, clinical, ultrasonological and endoscopic characteristics among all the study patients (n=360).
Variables
Age (years)
Gender
Male
Female
Cause of cirrhosis
Hepatitis C
Hepatitis B
Lab parameters
Albumin g/dl
ALT (IU)
AST (IU)
Platelets (/cmm)
Bilirubin (mg/dl)
CTP score
≤8
>8
MELD score
≤ 12
> 12
Ultrasound findings
Portal vein diameter (cm)
Spleen size (cm)
Spleen hilum varices
Ascites
HCC
Platelet/spleen diameter ratio
> 900
≤ 900
Esophageal varices
Yes
No

Portal gastropathy (n=300)
48.57 ± 12.47

No portal gastropathy (n=60)
50.07 ± 12.81

p-value
0.39

196 (65.3)
104 (34.7)

30 (50)
30 (50)

0.02

229 (76.3)
71 (23.7)

52 (86.7)
8 (13.3)

0.07

2.69
59.84
73.54
117.01
2.82

±
±
±
±
±

0.66
45.68
47.39
55.42
3.0

2.99 ± 0.71
57.16 ± 36
65.51 ± 41.75
166.77 ± 90.39
2.0 ± 1.93

0.001
0.66
0.22
< 0.001
0.004

174 (58)
126 (42)

50 (83.3)
10 (16.7)

< 0.001

139 (46.3)
161 (53.7)

57 (95)

< 0.001

1.14 ± 0.23
14.07 ± 2.94
150 (50)
143 (47.7)
25 (8.3)
916.08 ± 400
153 (51)
147 (49)

1.07 ± 0.18
12.05 ± 2.38
18 (30)
21 (35)
3 (5)
1476.83 ± 898.70
40 (66.7)
20 (33.3)

269 (89.7)
31 (10.3)

0.02
< 0.001
0.005
0.07
0.37
< 0.001
0.02

12 (20)
48 (80)

< 0.001

AST= Aspartate aminotransferase; ALT=Alanine aminotransferase; CTP score= Child Turcotte Pugh score; MELD score= Model for End Stage Liver Disease score; HCC= Hepatocellular carcinoma.

Univariate analysis of the factors which were correlating
the presence and severity of PHG were undertaken.
Factors found to be statistically significant in univariate
analysis were included in a multivariate logistic
regression model. Afterwards, a stepwise selection of
significant independent correlates for severity of PHG
performed. All p-values were two sided and considered
as statistically significant if < 0.05.

RESULTS
A total of 360 patients with viral cirrhosis who underwent
screening EGD, were included in this study. The mean
age was 49±12 years and there were 226 (62.8%)
males. 281 patients (78%) had cirrhosis due to HCV
infection, while 79 (22%) had HBV infection. There were
140 (38.9%) patients classified as Child Turcotte Pugh
(CTP) class A, 125 (34.7%) and 95 (26.4%) had class B
and C cirrhosis respectively.
A total 300 (83%) patients have portal hypertensive
gastropathy (PHG) on endoscopic examination of whom
71 (23.6%) had severe PHG. Comparisons of clinical
and laboratory parameters have shown statistically
significant values of serum total bilirubin of more than
2 mg/dl (p=0.004), serum albumin of less than 3 gm/dl
(p=0.001), platelets count of < 150,000 (p-value
< 0.001), CTP score > 8 (p < 0.001) and MELD score
> 12 (p < 0.001) among patients with PHG as compared
to those without portal gastropathy (Table I).
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Table II: Univariate logistic regression analysis for the prediction of
severe portal hypertensive gastropathy.
SE
Platelets
> 150,000/cmm
1.0
≤ 150,000/cmm
0.24
Albumin
> 3.5 grams/dl
1.0
≤ 3.5 grams/dl
0.34
Bilirubin
≤ 3 mg/dl
1.0
> 3 mg/dl
0.25
PT (control of 12)
≤ 4 seconds
1.0
> 4 seconds
0.22
CTP score
<8
1.0
≥8
0.26
MELD score
≤ 12
1.0
> 12
0.34
Platelets / spleen ratio
> 900
1.0
≤ 900
0.22
Esophageal varices
No
1.0
Yes
0.39

Odd ratio (95% CI)

p-value

1.78 (1.10-2.88)

0.01

2.79 (1.43-5.44)

0.003

1.26 (0.76-2.06)

0.35

1.73 (1.12-2.67)

0.01

7.89 (4.73-13.17)

< 0.001

19.47 (9.85-38.48)

< 0.001

3.84 (2.48-5.96)

< 0.001

11.07 (5.13-23.87)

< 0.001

CTP score= Child Turcotte Pugh score; MELD score= Model for End Stage Liver Disease
score; PT= Prothrombin time; SE= Standard error.

An increased portal vein diameter of greater than 1 cm
(p=0.02), enlarged spleen size of more than 12 cm
(p < 0.001) presence of splenic hilum varices (p=0.005)
and presence of esophageal varices (p < 0.001) were
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significant in patients with PHG as compared to without
it (Table I).
On univariate analysis, platelet counts < 150,000/cmm,
serum albumin < 3.5 gm/dl, prothrombin time > 4 seconds
above control, CTP score > 8, MELD score > 12, platelet/
spleen ratio < 900 and presence of esophageal varices
were significant factors in patients with severe PHG
(Table II).
Using stepwise logistic regression, CTP score > 8, MELD
score > 12, platelets/spleen ratio < 900 and presence of
EV were found to be independently significant factors in
patients with severe PHG (Table III).
The ROC curve had accuracy of 0.82 and the best cut
off for MELD score was 12 for the prediction of severe
PHG, with a sensitivity of 74% and a specificity of 78%
(Figure 1).
Table III: Multivariable logistic regression analysis for prediction of
severe portal hypertensive gastropathy.
Variable
Child score
<8
≥8
MELD score
≤ 12
> 12
Platelets / spleen ratio
> 900
≤ 900
Esophageal varices
No
Yes

SE

p-value

1.0
0.28

< 0.001

1.0
0.27

< 0.001

1.0
0.27

< 0.001

1.0
0.45

< 0.001

SE= Standard error.

DISCUSSION
This study was aimed to find the characteristic features
of PHG in patients with liver cirrhosis secondary to viral
etiology. The frequency of PHG in the study was found
to be 83% with 24% patients having severe portal
hypertensive gastropathy according to Baveno III
consensus statement. This high frequency of PHG and
its severity is also supported by other studies.5,17
Current study was focused on patients with viral
etiologies and excluded patients with alcohol intake,
which are distributed in significant proportion in other
studies.14 By excluding the alcoholics, authors tried to
have a homogenous group as the presence and severity
of PHG may fluctuate according to the level of alcohol
consumption.
Nearly 90% patients in present study with PHG had coexisting esophageal varices. None of these patients had
prior variceal obliteration. Furthermore, on univariate
and multivariate analysis the presence of esophageal
varices was noted to be a predictor of the presence of
severe PHG, again suggesting that portal hypertension
is a common pathogenic factor in both these conditions.
Esophageal varices are known to be a consequence of
portal hypertension and a high number of patients with

PHG have coexisting esophageal varices. Results from
the HALT-C trial showed a total of 40% patients with
PHG having varices compared to only 17% in subjects
without PHG.15
Multivariate analysis identified a CTP score of > 8 and a
MELD score of > 12 to be significantly associated with
presence and severity of PHG in patients with cirrhosis;
both these scores being reflective of severity of liver
cirrhosis. In a similar study, Dong et al. noted that 68% of
their patients with PHG had liver cirrhosis, with 27% of
patients with severe PHG being classified as CTP class
C and only 7% classified as class A.13 Similarly, a recently
published study by Young et al. demonstrated that the
MELD score of 11.3±3.5 is a predictor of severe PHG.6
This too implied an association, albeit controversial,
between severity of PHG and severity of liver dysfunction.
Patients with portal hypertension have decreased platelet
count and splenomegaly, with the thrombocytopenia
occurring secondary to shortened platelet life span and
decreased thrombopoeitin production while the enlarged
spleen size was due to congestion. In a recent study by
Giannini et al. it was shown that platelet to spleen ratio
could be used as a non-invasive predictor for the
presence of esophageal varices in patients with liver
cirrhosis.9 This study found the platelet to spleen ratio as
another significant factor for predicting the severity of
PHG.
Patients with PHG are at an increased risk of acute as
well as chronic gastrointestinal bleeding,8 although the
actual incidence of this bleeding is difficult to quantify
and distinguish from that due to esophageal varices.
The natural history of PHG is also not very clear, and it
is difficult to predict which patients will bleed secondary
to PHG and will thus be requiring treatment with beta
blockers. The identification of these non-invasive parameters in patients with PHG can be helpful in identifying
those with the severe form of PHG. These patients may
potentially benefit from medical therapy such as beta
blockers without needing to frequently undergo invasive
procedures such as endoscopy.

CONCLUSION
Frequency of PHG is high i.e. 83% while its severe form
was encountered in 24% patients with viral cirrhosis. A
MELD score > 12, CTP score ≥ 8 and spleen/platelets
ratio < 900 are helpful in identifying patients with severe
PHG. These factors can guide in identifying patients
needing early upper GI endoscopy and may benefit from
treatment with non-selective beta blockers.
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